M-M-R II SERBUK INJEKSI 0,5 ML

Šalis: Indonezija

kalba: indoneziečių

Šaltinis: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Parsisiųsti Prekės savybės (SPC)
15-11-2023

Veiklioji medžiaga:

MUMPS VIRUS VACCINE, LIVE; POLYRIBOSYL RIBITOL PHOSPHATE; RUBELLA VIRUS VACCINE LIVE ATTENUATED

Prieinama:

MERCK SHARP & DOHME PHARMA - Indonesia

INN (Tarptautinis Pavadinimas):

MUMPS VIRUS VACCINE, LIVE; POLYRIBOSYL RIBITOL PHOSPHATE; RUBELLA VIRUS VACCINE LIVE ATTENUATED

Dozė:

0,5 ML

Vaisto forma:

SERBUK INJEKSI

Vienetai pakuotėje:

DUS, 1 VIAL @ 0,5 ML + 1 VIAL PELARUT @ 0,7 ML

Pagaminta:

MERCK SHARP & DOHME - Netherlands

Leidimo data:

2018-12-28

Prekės savybės

                                M-M-R II
(MEASLES, MUMPS, and RUBELLA VIRUS VACCINE LIVE)
M-M-R® II (Measles, Mumps, and Rubella Virus Vaccine Live) is a live
virus vaccine for
vaccination against measles (rubeola), mumps and rubella (German
measles).
M-M-R II is a sterile lyophilized preparation of (1) ATTENUVAX®
(Measles Virus Vaccine
Live, MSD), a more attenuated line of measles virus, derived from
Enders' attenuated
Edmonston strain and propagated in chick embryo cell culture; (2)
MUMPSVAX® (Mumps
Virus Vaccine Live, MSD), the Jeryl Lynn™ (B level) strain of mumps
virus propagated in
chick embryo cell culture; and (3) MERUVAX® II (Rubella Virus Vaccine
Live, MSD), the
Wistar RA 27/3 strain of live attenuated rubella virus propagated in
WI-38 human diploid lung
fibroblasts.
The reconstituted vaccine is for subcutaneous administration. When
reconstituted as
directed, the dose for injection is 0.5 mL and contains not less than
1,000 CCID
50
(50% cell
culture infectious dose) of measles virus; 12,500 CCID
50
of mumps virus; and 1,000 CCID
50
of
rubella virus. Each dose of the vaccine is calculated to contain
sorbitol (14.5 mg), sodium
phosphate, sucrose (1.9 mg), hydrolyzed gelatin (14.5 mg), recombinant
human albumin (≤
0.3 mg), fetal bovine serum (<1
ppm), other buffer and media ingredients and approximately
25
mcg of neomycin. The product contains no preservative.
CLINICAL PHARMACOLOGY
Measles, mumps, and rubella are three common childhood diseases,
caused by measles
virus, mumps virus (paramyxoviruses), and rubella virus (togavirus),
respectively, that may
be associated with serious complications and/or death. For example,
pneumonia and
encephalitis are caused by measles. Mumps is associated with aseptic
meningitis, deafness
and orchitis; and rubella during pregnancy may cause congenital
rubella syndrome in the
infants of infected mothers.
Clinical
studies
of
284
triple
seronegative
children,
11 months
to
7
years
of
age,
demonstrated that M-M-R II is highly immunogenic and generally well
tolerated. In these
Disetujui Oleh BPOM : 09/
                                
                                Perskaitykite visą dokumentą
                                
                            

Peržiūrėti dokumentų istoriją